Skip to main content

Want a detailed portfolio tracker?

Invivyd (IVVD) P/E (2021 - 2026)

Invivyd (IVVD) P/E from Sep 30, 2021 to Jun 3, 2026. The TTM Invivyd (IVVD) P/E is -3.09. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Invivyd (IVVD)

YearP/EChange
2026-3.09-56.79%
2025-7.14+2191.89%
2024-0.31-87.75%
2023-2.54+112.34%
2022-1.20-100.09%
20211.35KN/A

Comparison Invivyd (IVVD) P/E with competitors

Invivyd (IVVD) P/E is -3.09.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.10-103.31%
ENLVEnlivex Therapeutics Ltd0.15-104.87%
FGENFibroGen Inc0.24-107.78%
TRAWTraws Pharma Inc0.47-115.32%
FBIOFortress Biotech Inc0.71-122.88%
CHRSCoherus Biosciences Inc0.98-131.70%
ORMPOramed Pharmaceuticals Inc1.47-147.75%
AGENAgenus Inc2.05-166.39%
VIVSVivoSim Labs Inc2.54-182.18%
INVAInnoviva Inc3.19-203.33%
CRMDCorMedix Inc3.65-218.15%
ABEOAbeona Therapeutics Inc4.20-236.28%
VXRTVaxart Inc4.26-238.11%
CVACCureVac N.V.4.45-244.08%
SRPTSarepta Therapeutics Inc4.62-249.86%
GLPGGalapagos NV4.86-257.47%
RIGLRigel Pharmaceuticals4.92-259.43%
ZVRAZevra Therapeutics Inc4.97-261.20%
ABUSArbutus Biopharma Corp5.69-284.53%
CGENCompugen Ltd7.38-339.30%
AUPHAurinia Pharmaceuticals Inc9.25-399.83%
ACADAcadia Pharmaceuticals Inc9.59-410.74%
OMEROmeros Corporation9.88-420.31%
PLXProtalix BioTherapeutics Inc9.91-421.14%
SPROSpero Therapeutics Inc10.73-447.90%
ADMAAdma Biologics Inc11.33-467.21%
SVASinovac Biotech Ltd11.44-470.63%
TBPHTheravance Biopharma Inc11.78-481.67%
HRMYHarmony Biosciences Holdings Inc12.18-494.75%
TGTXTG Therapeutics Inc13.18-527.13%
INCYIncyte Corp13.38-533.70%
SABSSAB Biotherapeutics Inc14.06-555.60%
XOMAXOMA Corp14.95-584.36%
REGNRegeneron Pharmaceuticals Inc14.98-585.49%
PBYIPuma Biotechnology Inc15.05-587.77%
EXELExelixis Inc15.79-611.89%
NAGENiagen Bioscience Inc16.35-630.05%
CPRXCatalyst Pharmaceuticals Inc17.34-662.13%
MDXGMimedx Group Inc17.38-663.12%
ARGXArgen X SE23.07-847.73%
HALOHalozyme Therapeutics Inc23.20-851.91%
XOMAOXOMA Corp25.34-921.40%
VRTXVertex Pharmaceuticals Inc25.66-931.48%
XOMAPXOMA Corp25.67-931.94%
CTMXCytomX Therapeutics Inc25.70-932.84%
ASNDAscendis Pharma A/S26.35-954.11%
RPRXRoyalty Pharma plc - Class A27.50-991.10%
SLNOSoleno Therapeutics Inc29.02-1040.36%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1078.31%
BMRNBiomarin Pharmaceutical Inc37.51-1315.57%
APLSApellis Pharmaceuticals Inc39.02-1364.64%
KRYSKrystal Biotech Inc39.70-1386.56%
GMABGenmab40.20-1402.96%
ONCBeiGene Ltd67.03-2272.28%
TECHBio-Techne Corp68.59-2323.10%
VCELVericel Corp80.63-2713.11%
PHARPharming Group N.V.87.74-2943.57%
ALNYAlnylam Pharmaceuticals Inc124.93-4148.98%
TLXTelix Pharmaceuticals Ltd139.89-4633.72%
CORTCorcept Therapeutics Inc158.39-5233.24%